Abstract:1048 Background: Patients (pts) with high-risk (HR) locally advanced/inflammatory breast cancer (LABC/IBC), and oligometastatic (≤ 3 sites) stage IV metastatic breast cancer (MBC) are likely to relapse/progress early. High dose chemotherapy (HDCT) followed by stem cell rescue (SCR) may prolong progression/relapse-free (PFS/RFS) and overall survival (OS) in selected pts. METHODS Between 1998 and 2009, 104 eligible pts were consented and treated sequentially on 2 City of Hope Cancer Center IRB-approved HDCT protocols. HDCT consisted of carboplatin, thiotepa, and cyclophosphamide (STAMP-V), doxorubicin, paclitaxel, and cyclophosphamide (ACT), or tandem melphalan and STAMP-V (administered to all pts with MBC and followed by targeted radiation therapy), supported by SCR. RESULTS Ninety-two pts were diagnosed with LABC/IBC (16 IBC), and 12 had MBC. Among the 92 HR pts, by AJCC 7th edition criteria,14 pts were treated for IIIA, 10 for IIIB, and 68 for IIIC BC. The median age for pts with LABC/IBC was 50 years (range 28-66). Neoadjuvant chemotherapy (NCT) was prescribed to 34% of pts. HDCT was prescribed a median of 8.1 (range 4.4-14.5) months (mos) after diagnosis. The median follow-up of alive LABC/IBC patients was 84 mths (range 6-136). Hormone receptors (HR) were positive in 74% of LABC/IBC pts, and HER2 was overexpressed in 23%. Hormone receptor status (HR) positively impacted the likelihood of RFS and OS (HR+ vs HR- 5-yr RFS 61% vs 32%, p=.008). Tumor grade, histopathology including IBC, HER2 and triple negative status, or receipt of NCT had no statistically significant effect on survival, although higher stage disease led to worse long term outcomes (5-yr RFS for Stage IIIA, IIIB, IIIC was 85%, 68%, 45%, p=.051, with 5-yr OS 92%, 90%, and 64%, respectively, p=.051). For MBC (12 pts), the median follow-up of alive pts is 40 months, (range 24-62), resulting in a 3-yr PFS of 49% 95% CI (19%-73%), and 3-yr OS of 73% 95% CI (38%-91%). One pt died of HDCT-associated sepsis, and 1 pt developed papillary thyroid cancer. CONCLUSIONS The favorable long term PFS/RFS and OS in this selected pt population warrants validation in molecularly defined subgroups with LABC/IBC/MBC.

Position Prediction of Ball and Fuzzy Controller for Shooting Action in A Soccer Robot System

An adaptive trajectory prediction method for ping-pong robots

Real-time vision system for a Ping-Pong robot

Spin Observation and Trajectory Prediction of a Ping-Pong Ball

A Shooting Algorithm for Soccer Robot Based on a Dynamic Referencing Circle

Accurate Real-Time Ball Trajectory Estimation with Onboard Stereo Camera System for Humanoid Ping-Pong Robot

Real-time Accurate Ball Trajectory Estimation with "asynchronous" Stereo Camera System for Humanoid Ping-Pong Robot.

A Learning Framework Towards Real-Time Detection and Localization of a Ball for Robotic Table Tennis System

Research on Humanoid Robot Soccer System Based on Fuzzy Logic

Real-Time Spin Estimation of Ping-Pong Ball Using Its Natural Brand.

Robotic velocity generation using neural network

Model Based Motion State Estimation and Trajectory Prediction of Spinning Ball for Ping-Pong Robots Using Expectation-Maximization Algorithm

Robust Real-Time Motion Retargeting Via Neural Latent Prediction

Shooting Action Control of Soccer Robot Based on Genetic-fuzzy Algorithm

The Application Research of a Fuzzy Controller on Robot

A New Real-time Collision Prediction Model for Soccer Robots

Competition Analysis System For Soccer Robots Based On Global Vision And Trajectory Restrictions

Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk locally advanced/inflammatory and metastatic breast cancer.

Trajectory Prediction of Spinning Ball Based on Fuzzy Filtering and Local Modeling for Robotic Ping–Pong Player

Generation a shooting on the walking for soccer simulation 3D league using Q-learning algorithm

Hierarchical Reinforcement Learning for Precise Soccer Shooting Skills using a Quadrupedal Robot